0000905718-22-000533.txt : 20220405 0000905718-22-000533.hdr.sgml : 20220405 20220405081559 ACCESSION NUMBER: 0000905718-22-000533 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220405 DATE AS OF CHANGE: 20220405 EFFECTIVENESS DATE: 20220405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-440338 FILM NUMBER: 22805280 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 D 1 primary_doc.xml X0708 D LIVE 0001540159 Edesa Biotech, Inc. 100 SPY COURT MARKHAM A6 ONTARIO, CANADA L3R 5H6 289-800-9600 BRITISH COLUMBIA, CANADA None Stellar Biotechnologies, Inc. Corporation true Kathi Niffenegger 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Executive Officer Jennifer Chao 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Lorin Johnson 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Sean MacDonald 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Pardeep Nijhawan 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Executive Officer Director Frank Oakes 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Paul Pay 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Carlo Sistilli 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Director Michael Brooks 100 Spy Court Markham A6 ONTARIO, CANADA L3R 5H6 Executive Officer Biotechnology Decline to Disclose 06b false 2022-03-21 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE, 4TH FLOOR NEW YORK NY NEW YORK 10022 All States false Indefinite 0 Indefinite Value of warrants indeterminable as they were issued in connection with a concurrent registered direct offering of common stock. false 1 0 true 0 true See Item 13. Fees payable to placement agent solely for the issuance of the warrants indeterminable. Excludes value of warrants issued to placement agent. 0 true false Edesa Biotech, Inc. /s/ Kathi Niffenegger Kathi Niffenegger Chief Financial Officer 2022-04-05